Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10368838" target="_blank" >RIV/00216208:11110/17:10368838 - isvavai.cz</a>

Alternative codes found

RIV/00064165:_____/17:10368838

Result on the web

<a href="https://academic.oup.com/eurheartj/article/38/35/2649/3893585" target="_blank" >https://academic.oup.com/eurheartj/article/38/35/2649/3893585</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1093/eurheartj/ehx321" target="_blank" >10.1093/eurheartj/ehx321</a>

Result language

angličtina

Original language name

Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

Original language description

The cardiovascular system and in particular the myocardium are often critical targets in Systemic immune-mediated diseases (SIDs), even in asymptomatic patients, leading to a relevant negative burden on prognosis. However, there are at present no studies to recommend cardiac screening in all patients regardless of the clinical suspicion. Therefore, management of patients with SIDs should always include cardiological screening and follow-up in patients with clinically suspected cardiac involvement. It is hoped that this document will provide a first orientation to cardiologists and non-cardiology physicians in selecting an appropriate multidisciplinary diagnostic workup in SIDs-related myocardial disease, as well as personalised treatment. Furthermore, it is hoped that cardiologists will actively participate to conception and design of future immunosuppressive/immunomodulatory trials in well-characterized groups of SIDs patients with early/subclinical as well as established myocardial involvement. In fact, at present there is a relative paucity of evidence-based treat-to-target regimens in SIDs patients with myocardial involvement besides empirically driven intensification of conventional immunosuppression.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30201 - Cardiac and Cardiovascular systems

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2017

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

European Heart Journal

ISSN

0195-668X

e-ISSN

—

Volume of the periodical

38

Issue of the periodical within the volume

35

Country of publishing house

GB - UNITED KINGDOM

Number of pages

14

Pages from-to

2649-2662

UT code for WoS article

000410679500007

EID of the result in the Scopus database

2-s2.0-85029761067